Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510 — Englewood, Colorado

Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510 is a clinical research site located in Englewood, Colorado, United States 80113-2776.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Parkinson Disease.

Sponsors: Prevail Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510?

Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510 conducted?

Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510 has 1 clinical trials on record, with 1 currently active. Their work covers Parkinson Disease.

Is Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510 accredited by Crixeo Health?

Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Clinical Research - CenExel - PPDS, 701 East Hampden Avenue Suite 510?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.